Kala Pharmaceuticals CEO Mark Iwicki's 2022 pay falls 33% to $1.9M
Kala Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: March 13, 2023
Kala Pharmaceuticals reported fiscal year 2022 executive compensation information on March 13, 2023.
In 2022, three executives at Kala Pharmaceuticals received on average a compensation package of $1.3M, a 28% decrease compared to previous year.
Average pay of disclosed executives at Kala Pharmaceuticals
Mark Iwicki, Chief Executive Officer, received $1.9M in total, which decreased by 33% compared to 2021. 41% of Iwicki's compensation, or $771K, was in option awards. Iwicki also received $409K in bonus, $682K in salary, as well as $6.1K in other compensation.
Todd Bazemore, Chief Operating Officer, received a compensation package of $1M, which decreased by 24% compared to previous year. 50% of the compensation package, or $515K, was in salary.
Kim Brazzell, Chief Medical Officer, earned $994K in 2022, a 25% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on March 13, 2023.